Direct to Phase 2 NIH SBIR: Key Differences Explained! #shorts
7 Dec 2025 · 0 min
0:15
The video explains that a Direct-to-Phase II NIH SBIR or STTR application is essentially identical to a standard Phase II application, with the sole distinction that startups are not required to have previously received a Phase I SBIR award. This means companies can apply directly to Phase II without completing Phase I, simplifying the pathway for eligible startups.
